Question 1

What does Swedish Orphan Biovitrum do?

Accepted Answer

Swedish Orphan Biovitrum is a global biopharma company that manufactures and supplies rare disease medicines.

Question 2

In what sectors does Swedish Orphan Biovitrum operate?

Accepted Answer

Swedish Orphan Biovitrum operates in Biotechnology, Genetics, Health Care, Medical, Pharmaceutical.

Question 3

How many companies has Swedish Orphan Biovitrum acquired?

Accepted Answer

Swedish Orphan Biovitrum has made 6 acquisitions between 2005-2025, with a total disclosed deal value of $3.8B.

Question 4

What companies are owned by Swedish Orphan Biovitrum?

Accepted Answer

Companies acquired by Swedish Orphan Biovitrum include Arthrosi Therapeutics, CTI BioPharma, Dova Pharmaceuticals, Swedish Orphan International Manufacturing, Arexis AB, Cambridge Biotechnology.

Question 5

What are Swedish Orphan Biovitrum's major acquisitions?

Accepted Answer

Swedish Orphan Biovitrum's largest acquisitions include CTI BioPharma ($1.7B, 2023), Arthrosi Therapeutics ($950.0M, 2025), Dova Pharmaceuticals ($915.0M, 2019), Swedish Orphan International Manufacturing ($273.8M, 2009).

Question 6

What is Swedish Orphan Biovitrum's largest acquisition?

Accepted Answer

Swedish Orphan Biovitrum's largest disclosed acquisition is CTI BioPharma for $1.7B (2023).

Question 7

What was Swedish Orphan Biovitrum's first acquisition?

Accepted Answer

Swedish Orphan Biovitrum's first recorded acquisition was Cambridge Biotechnology in 2005.

Question 8

What was Swedish Orphan Biovitrum's most recent acquisition?

Accepted Answer

Swedish Orphan Biovitrum's most recent acquisition is Arthrosi Therapeutics, announced December 2025 for $950.0M.

Question 9

What is the average deal size for Swedish Orphan Biovitrum acquisitions?

Accepted Answer

The average disclosed deal size for Swedish Orphan Biovitrum acquisitions is $959.7M.

Question 10

What is the median deal size for Swedish Orphan Biovitrum acquisitions?

Accepted Answer

The median disclosed deal size for Swedish Orphan Biovitrum acquisitions is $932.5M. The median is often lower than the average because a few very large deals pull the average up.

Question 11

How much has Swedish Orphan Biovitrum spent on acquisitions?

Accepted Answer

Swedish Orphan Biovitrum has spent at least $3.8B across its disclosed acquisitions (of 6 total deals; some prices are undisclosed).

Question 12

Which sector has Swedish Orphan Biovitrum spent the most on?

Accepted Answer

Swedish Orphan Biovitrum has committed the most disclosed capital to Biotechnology companies — about $2.6B across its deals in that sector.

Question 13

What sectors does Swedish Orphan Biovitrum usually acquire in?

Accepted Answer

Swedish Orphan Biovitrum most frequently acquires companies in Biotechnology, Health Care, Pharmaceutical.

Question 14

In which sector has Swedish Orphan Biovitrum made the most acquisitions?

Accepted Answer

Swedish Orphan Biovitrum has made the most acquisitions in the Biotechnology sector.

Question 15

In which year did Swedish Orphan Biovitrum make the most acquisitions?

Accepted Answer

Swedish Orphan Biovitrum made the most acquisitions in 2005, with 2 deals.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Swedish Orphan Biovitrum

Company Details

Funding & Financials

IPO & Stock

Web Traffic

Technology & IP

Investor Activity

Company Info

Signals & Scores

Investments by Swedish Orphan Biovitrum

Acquisitions by Swedish Orphan Biovitrum

Key People at Swedish Orphan Biovitrum

Explore 200,000+ acquisitions — free

Recent News related to Swedish Orphan Biovitrum

FAQs about Swedish Orphan Biovitrum

People who checked this page also checked these